What's Going With Pulse Biosciences Stock On Monday?
Pulse Biosciences (PLSE) is witnessing stock price appreciation following the release of favorable clinical data from its nPulse Cardiac Catheter first-in-human feasibility study. This development indicates the technology's potential, which could lead to further investment interest and future medical applications.
View signal analysis